BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38850734)

  • 1. Advancements of CRISPR technology in public health-related analysis.
    Gu X; Tang Q; Zhu Y; Sun C; Wu L; Ji H; Wang Q; Wu L; Qin Y
    Biosens Bioelectron; 2024 Oct; 261():116449. PubMed ID: 38850734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing.
    Bao M; Chen Q; Xu Z; Jensen EC; Liu C; Waitkus JT; Yuan X; He Q; Qin P; Du K
    ACS Sens; 2021 Jul; 6(7):2497-2522. PubMed ID: 34143608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System.
    Wei C; Lei X; Yu S
    ACS Synth Biol; 2024 Jun; 13(6):1633-1646. PubMed ID: 38860462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas based molecular diagnostics for foodborne pathogens.
    Lu Y; Yang H; Bai J; He Q; Deng R
    Crit Rev Food Sci Nutr; 2024; 64(16):5269-5289. PubMed ID: 36476134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cas14a1-mediated nucleic acid detectifon platform for pathogens.
    Ge X; Meng T; Tan X; Wei Y; Tao Z; Yang Z; Song F; Wang P; Wan Y
    Biosens Bioelectron; 2021 Oct; 189():113350. PubMed ID: 34049081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
    Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paper-based loop-mediated isothermal amplification and CRISPR integrated platform for on-site nucleic acid testing of pathogens.
    Sen A; Masetty M; Weerakoon S; Morris C; Yadav JS; Apewokin S; Trannguyen J; Broom M; Priye A
    Biosens Bioelectron; 2024 Aug; 257():116292. PubMed ID: 38653014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas and Argonaute-Based Biosensors for Pathogen Detection.
    Yang Z; Mao S; Wang L; Fu S; Dong Y; Jaffrezic-Renault N; Guo Z
    ACS Sens; 2023 Oct; 8(10):3623-3642. PubMed ID: 37819690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in CRISPR sensing and detection technology].
    Wang J; Zhao P; Qin M; Zhao Y; Liu C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):367-377. PubMed ID: 38369827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of CRISPR/Cas systems in the nucleic acid detection of pathogens: a review].
    Li M; Qin Z; Yin K; Zheng B
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Feb; 35(1):98-103. PubMed ID: 36974023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/cas systems redefine nucleic acid detection: Principles and methods.
    Wang M; Zhang R; Li J
    Biosens Bioelectron; 2020 Oct; 165():112430. PubMed ID: 32729545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas-engineered technology: Innovative approach for biosensor development.
    Zavvar TS; Khoshbin Z; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Biosens Bioelectron; 2022 Oct; 214():114501. PubMed ID: 35777218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas12a System for Biosensing and Gene Regulation.
    Shi Y; Fu X; Yin Y; Peng F; Yin X; Ke G; Zhang X
    Chem Asian J; 2021 Apr; 16(8):857-867. PubMed ID: 33638271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas systems mediated biosensing and applications in food safety detection.
    Liu J; Wu D; Chen J; Jia S; Chen J; Wu Y; Li G
    Crit Rev Food Sci Nutr; 2024; 64(10):2960-2985. PubMed ID: 36218189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point-of-Care Diagnosis.
    Dai Y; Wu Y; Liu G; Gooding JJ
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20754-20766. PubMed ID: 32521081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.